Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?

Anne C Bay-JensenAnne Sofie SiebuhrDres DamgaardPatryk DrobinskiChristian ThudiumJoachim MortensenClaus H Nielsen

Published in: Expert review of proteomics (2021)

Although many biochemical markers have been identified and tested, few are currently being used in clinical practice. As more treatment options are becoming available, the need for precision medicine tools that can aid physicians and patients in choosing the right treatment is growing.

Keyphrases

rheumatoid arthritis
clinical practice
end stage renal disease
ejection fraction
newly diagnosed
primary care
prognostic factors
disease activity
ankylosing spondylitis
systemic lupus erythematosus